We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
-12.46%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$208B
AUM Growth
-$32.5B
Cap. Flow
+$1.13B
Cap. Flow %
0.54%
Top 10 Hldgs %
18.46%
Holding
7,612
New
581
Increased
2,367
Reduced
3,311
Closed
633

Top Buys

Rank Stock Value
1
TD icon
Toronto Dominion Bank
TD
+$471M
2
ENB icon
Enbridge
ENB
+$330M
3
LIN icon
Linde
LIN
+$253M
4
BNS icon
Scotiabank
BNS
+$242M
5
AAPL icon
Apple
AAPL
+$187M

Sector Composition

Rank Sector Weight
1 Financials 20.78%
2 Technology 7.98%
3 Energy 7.91%
4 Healthcare 7.37%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YARW
6526
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
0
WATT icon
6527
CALL
Energous
WATT
$82M
0
WMS icon
6528
Advanced Drainage Systems
WMS
$11.3B
$1K ﹤0.01%
55
-498
-90% -$13.4K
XPL icon
6529
Solitario Resources
XPL
$73.9M
$1K ﹤0.01%
2,487
+1,335
+116% +$404
SER icon
6530
Serina Therapeutics
SER
$42.7M
$1K ﹤0.01%
+13
New +$1.65K
TECX
6531
Tectonic Therapeutic
TECX
$664M
$1K ﹤0.01%
5
-5
-50% -$1.52K
QCLS
6532
Q/C Technologies Inc
QCLS
$22.5M
0
CMRX
6533
DELISTED
Chimerix, Inc.
CMRX
$1K ﹤0.01%
600
-963
-62% -$3.22K
ITI
6534
DELISTED
Iteris, Inc.
ITI
$1K ﹤0.01%
323
-579
-64% -$2.48K
TELL
6535
CALL
DELISTED
Tellurian Inc.
TELL
$1K ﹤0.01%
+100
New +$773
CBAY
6536
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
94
-1,013
-92% -$9.64K
FTCH
6537
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$1K ﹤0.01%
+39
New +$845
EVLO
6538
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$1K ﹤0.01%
3
-8
-73% -$1.61K
JNCE
6539
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1K ﹤0.01%
300
-316
-51% -$1.48K
NH
6540
DELISTED
NantHealth, Inc
NH
$1K ﹤0.01%
66
-31
-32% -$543
USWS
6541
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$1K ﹤0.01%
+5
New +$928
AMPE
6542
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$1K ﹤0.01%
8
-6
-43% -$921
NBEV
6543
PUT
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1K ﹤0.01%
+100
New +$524
SRRA
6544
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1K ﹤0.01%
28
WVFC
6545
DELISTED
WVS Financial Corp
WVFC
$1K ﹤0.01%
50
-4,883
-99% -$73.1K
STXB
6546
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$1K ﹤0.01%
37
-46
-55% -$948
LEVL
6547
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$1K ﹤0.01%
57
-33
-37% -$873
KRA
6548
DELISTED
Kraton Corporation
KRA
$1K ﹤0.01%
49
-934
-95% -$27.4K
OMP
6549
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$1K ﹤0.01%
+70
New +$1.43K
ODT
6550
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$1K ﹤0.01%
51
-87
-63% -$1.35K

Similar funds

Royal Bank of Canada's Q4 2018 Portfolio in Review

As of Q4 2018, Royal Bank of Canada held 7,612 positions worth $208B, down 14% from $241B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Royal Bank of Canada's Q4 2018 filing shows 581 new, 2,367 increased, 3,311 reduced and 633 closed positions. Its largest new stake was Linde: 1,601,713 shares worth $250M. The largest sale was AT&T, an estimated $224M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Energy.

  • Royal Bank of Canada's largest Q4 2018 buy was Linde: 1,601,713 shares worth $250M.
  • Royal Bank of Canada added most to Toronto Dominion Bank in Q4 2018, an estimated $471M increase.
  • Royal Bank of Canada's biggest Q4 2018 reduction was AT&T, cutting an estimated $224M.
  • Royal Bank of Canada fully exited Praxair Inc in Q4 2018, selling an estimated $191M.
  • Royal Bank of Canada's ten largest holdings make up 18% of its $208B portfolio in Q4 2018.
  • Royal Bank of Canada opened 581 new positions and closed 633 in Q4 2018.
  • Royal Bank of Canada's portfolio value fell 14% quarter-over-quarter to $208B.

Based on Royal Bank of Canada's 13F filing for Q4 2018, filed 14 Feb 2019.